Most Clicked StoriesMore >


Cost to develop new drug is $2.56B, Tufts center reports

FDLI SmartBrief | Nov 19, 2014

The cost of bringing a new drug to market is $2.56 billion, according to a report from the Tufts Center for the Study of Drug Development. The figure is more than double the center's last estimate of an inflation-adjusted $1.04 billion in 2003. Bloomberg (11/18) Reuters (11/18) American City Business Journals (11/18)


FDA sued by Ranbaxy for voiding approvals of Valcyte, Nexium generics

FDLI SmartBrief | Nov 19, 2014

Wider disclosure of drug clinical trials proposed in U.S.

FDLI SmartBrief | Nov 20, 2014

Purdue Pharma's harder-to-abuse painkiller wins FDA approval

FDLI SmartBrief | Nov 21, 2014

Gilead buys Knight Therapeutics' priority-review voucher for $125M

FDLI SmartBrief | Nov 20, 2014

Senate panel to focus on rising prices of generic meds today

FDLI SmartBrief | Nov 20, 2014

As generic drug prices soar, lawmakers look to help lessen the burden

FDLI SmartBrief | Nov 25, 2014

Pharmacists praise Congress for probe on rising generic drug costs

FDLI SmartBrief | Nov 19, 2014

India plans to put pharma-tied agencies under single authority

FDLI SmartBrief | Nov 24, 2014

White paper: Biologic market competition is hampered by FDA

FDLI SmartBrief | Nov 20, 2014


Find FDLI SmartBrief Issues by Date:



FDLI News More >


Enforcement, Litigation, and Compliance Conference session -- Criminal and Civil Enforcement: Domestic and International Developments

FDLI SmartBrief | Nov 25, 2014

Introduction to Drug and Regulation -- session highlight: Violations and Enforcement

FDLI SmartBrief | Nov 25, 2014

Enforcement, Litigation, and Compliance Conference -- Interagency Enforcement Action: An Inside Look

FDLI SmartBrief | Nov 24, 2014

FDLI and UMD discuss DQSA -- next week!

FDLI SmartBrief | Nov 24, 2014

FDLI's DQSA Conference coming up Dec. 3!

FDLI SmartBrief | Nov 21, 2014




Sign up for FDLI SmartBrief



Designed specifically for professionals involved in the food and drug law community, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more

Recent Poll view more polls


What affect do you think this year's media focus on imported drug, food and medical device product safety will have in 2010?

Chart.